| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Barrett Esophagus | 57 | 2022 | 569 | 16.060 |
Why?
|
| Esophageal Neoplasms | 53 | 2022 | 3168 | 8.600 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 20 | 2024 | 421 | 6.450 |
Why?
|
| Adenocarcinoma | 51 | 2022 | 7789 | 5.610 |
Why?
|
| Stomach Neoplasms | 17 | 2024 | 2278 | 4.760 |
Why?
|
| Carcinoma, Hepatocellular | 25 | 2024 | 2027 | 4.750 |
Why?
|
| Helicobacter Infections | 16 | 2023 | 1216 | 4.720 |
Why?
|
| Gastroesophageal Reflux | 19 | 2021 | 334 | 4.370 |
Why?
|
| Precancerous Conditions | 12 | 2023 | 1058 | 3.750 |
Why?
|
| Helicobacter pylori | 15 | 2023 | 1295 | 3.710 |
Why?
|
| Liver Neoplasms | 27 | 2024 | 4557 | 3.690 |
Why?
|
| Alcohol Drinking | 9 | 2022 | 551 | 3.260 |
Why?
|
| Risk Factors | 78 | 2024 | 17523 | 2.960 |
Why?
|
| Liver Cirrhosis | 17 | 2024 | 941 | 2.740 |
Why?
|
| Incidence | 39 | 2024 | 5673 | 2.390 |
Why?
|
| Life Style | 7 | 2022 | 612 | 2.140 |
Why?
|
| Mendelian Randomization Analysis | 9 | 2021 | 100 | 1.820 |
Why?
|
| Veterans | 15 | 2023 | 1641 | 1.800 |
Why?
|
| Smoking | 11 | 2023 | 2440 | 1.700 |
Why?
|
| Obesity | 18 | 2023 | 2884 | 1.680 |
Why?
|
| Humans | 178 | 2024 | 261506 | 1.660 |
Why?
|
| United States | 39 | 2024 | 15433 | 1.640 |
Why?
|
| Middle Aged | 97 | 2024 | 86204 | 1.600 |
Why?
|
| Metaplasia | 11 | 2022 | 383 | 1.560 |
Why?
|
| Cross-Sectional Studies | 23 | 2023 | 4314 | 1.550 |
Why?
|
| Demography | 6 | 2021 | 435 | 1.520 |
Why?
|
| Male | 112 | 2024 | 123000 | 1.520 |
Why?
|
| Population Surveillance | 5 | 2022 | 627 | 1.440 |
Why?
|
| Prevalence | 20 | 2022 | 3260 | 1.410 |
Why?
|
| Case-Control Studies | 28 | 2021 | 6100 | 1.410 |
Why?
|
| Aged | 75 | 2023 | 70117 | 1.380 |
Why?
|
| Female | 111 | 2024 | 141928 | 1.350 |
Why?
|
| Registries | 16 | 2024 | 2170 | 1.350 |
Why?
|
| Risk Assessment | 27 | 2023 | 6869 | 1.330 |
Why?
|
| Veterans Health | 2 | 2020 | 181 | 1.290 |
Why?
|
| Proton Pump Inhibitors | 7 | 2023 | 249 | 1.270 |
Why?
|
| Colorectal Neoplasms | 10 | 2023 | 3578 | 1.270 |
Why?
|
| Early Detection of Cancer | 7 | 2023 | 1258 | 1.260 |
Why?
|
| Stomach | 2 | 2022 | 387 | 1.250 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2019 | 849 | 1.250 |
Why?
|
| Socioeconomic Factors | 8 | 2023 | 1225 | 1.180 |
Why?
|
| Nutrition Surveys | 7 | 2022 | 295 | 1.170 |
Why?
|
| Esophagoscopy | 5 | 2022 | 291 | 1.170 |
Why?
|
| Adult | 65 | 2024 | 77950 | 1.150 |
Why?
|
| Intestines | 3 | 2021 | 686 | 1.140 |
Why?
|
| Odds Ratio | 13 | 2021 | 2316 | 1.120 |
Why?
|
| Body Height | 4 | 2018 | 231 | 1.110 |
Why?
|
| Colonic Polyps | 3 | 2023 | 209 | 1.100 |
Why?
|
| Polymorphism, Single Nucleotide | 13 | 2022 | 4549 | 1.060 |
Why?
|
| Mexican Americans | 2 | 2018 | 322 | 1.050 |
Why?
|
| Global Health | 5 | 2022 | 657 | 1.040 |
Why?
|
| Texas | 16 | 2023 | 6311 | 1.030 |
Why?
|
| Anthropometry | 2 | 2017 | 269 | 1.010 |
Why?
|
| Decision Support Techniques | 5 | 2020 | 622 | 0.990 |
Why?
|
| Logistic Models | 14 | 2021 | 3441 | 0.950 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2023 | 1833 | 0.940 |
Why?
|
| Models, Statistical | 3 | 2016 | 1171 | 0.930 |
Why?
|
| Hepatitis C | 3 | 2023 | 524 | 0.890 |
Why?
|
| Leptin | 2 | 2015 | 295 | 0.880 |
Why?
|
| Hepatitis C, Chronic | 2 | 2018 | 451 | 0.850 |
Why?
|
| Endoscopy, Digestive System | 5 | 2018 | 202 | 0.850 |
Why?
|
| Elasticity Imaging Techniques | 2 | 2022 | 171 | 0.830 |
Why?
|
| Endoscopy, Gastrointestinal | 7 | 2023 | 375 | 0.810 |
Why?
|
| Body Mass Index | 7 | 2019 | 2203 | 0.800 |
Why?
|
| Tobacco Smoking | 1 | 2021 | 38 | 0.800 |
Why?
|
| Minority Groups | 2 | 2020 | 322 | 0.790 |
Why?
|
| Health Status Disparities | 3 | 2022 | 291 | 0.770 |
Why?
|
| Esophagogastric Junction | 2 | 2016 | 543 | 0.760 |
Why?
|
| Colonic Neoplasms | 2 | 2021 | 1390 | 0.750 |
Why?
|
| Point-of-Care Testing | 1 | 2020 | 24 | 0.740 |
Why?
|
| Aged, 80 and over | 24 | 2024 | 29902 | 0.740 |
Why?
|
| Rectal Neoplasms | 2 | 2021 | 1202 | 0.740 |
Why?
|
| Gallbladder Neoplasms | 1 | 2022 | 245 | 0.720 |
Why?
|
| Histamine H2 Antagonists | 1 | 2019 | 50 | 0.710 |
Why?
|
| Stomach Diseases | 1 | 2020 | 62 | 0.710 |
Why?
|
| United States Department of Veterans Affairs | 4 | 2021 | 605 | 0.710 |
Why?
|
| Electric Impedance | 2 | 2017 | 100 | 0.700 |
Why?
|
| Obesity, Abdominal | 2 | 2016 | 43 | 0.680 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2021 | 5539 | 0.650 |
Why?
|
| SEER Program | 5 | 2024 | 1000 | 0.650 |
Why?
|
| Cohort Studies | 16 | 2022 | 9244 | 0.640 |
Why?
|
| Young Adult | 22 | 2024 | 21445 | 0.630 |
Why?
|
| Carcinoma, Squamous Cell | 6 | 2022 | 5437 | 0.630 |
Why?
|
| Disease Progression | 10 | 2022 | 6682 | 0.610 |
Why?
|
| Neoplasms | 6 | 2022 | 15193 | 0.610 |
Why?
|
| Klatskin Tumor | 1 | 2017 | 29 | 0.600 |
Why?
|
| Diet | 4 | 2022 | 1440 | 0.580 |
Why?
|
| Predictive Value of Tests | 10 | 2020 | 4892 | 0.580 |
Why?
|
| Virus Diseases | 1 | 2020 | 398 | 0.580 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2016 | 84 | 0.560 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 598 | 0.550 |
Why?
|
| Aspirin | 2 | 2016 | 455 | 0.550 |
Why?
|
| Tea | 1 | 2015 | 43 | 0.550 |
Why?
|
| Coffee | 1 | 2015 | 33 | 0.540 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2016 | 521 | 0.540 |
Why?
|
| Retrospective Studies | 25 | 2023 | 37905 | 0.540 |
Why?
|
| Acculturation | 1 | 2016 | 112 | 0.540 |
Why?
|
| Cold Temperature | 1 | 2015 | 121 | 0.540 |
Why?
|
| Fibrosis | 4 | 2024 | 793 | 0.540 |
Why?
|
| Environmental Exposure | 1 | 2018 | 288 | 0.530 |
Why?
|
| Liver Transplantation | 2 | 2021 | 1112 | 0.530 |
Why?
|
| Overweight | 3 | 2023 | 484 | 0.530 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2017 | 334 | 0.520 |
Why?
|
| Serum | 1 | 2015 | 68 | 0.520 |
Why?
|
| Adipokines | 1 | 2015 | 96 | 0.520 |
Why?
|
| Genome-Wide Association Study | 12 | 2022 | 2265 | 0.510 |
Why?
|
| Hot Temperature | 1 | 2015 | 281 | 0.500 |
Why?
|
| Surgical Procedures, Operative | 1 | 2018 | 383 | 0.500 |
Why?
|
| Adiponectin | 1 | 2015 | 163 | 0.500 |
Why?
|
| Melatonin | 1 | 2014 | 46 | 0.480 |
Why?
|
| Birth Weight | 1 | 2015 | 374 | 0.470 |
Why?
|
| Chemoprevention | 1 | 2015 | 241 | 0.470 |
Why?
|
| Pregnancy Outcome | 2 | 2014 | 643 | 0.460 |
Why?
|
| Exercise | 4 | 2022 | 1183 | 0.460 |
Why?
|
| Models, Genetic | 1 | 2017 | 1113 | 0.460 |
Why?
|
| Cost of Illness | 1 | 2016 | 498 | 0.460 |
Why?
|
| Alanine Transaminase | 3 | 2020 | 227 | 0.450 |
Why?
|
| Liver Diseases, Alcoholic | 2 | 2023 | 56 | 0.430 |
Why?
|
| Europe | 5 | 2019 | 649 | 0.430 |
Why?
|
| Multivariate Analysis | 7 | 2021 | 4298 | 0.430 |
Why?
|
| Bile Duct Neoplasms | 1 | 2017 | 493 | 0.430 |
Why?
|
| Cholangiocarcinoma | 1 | 2017 | 493 | 0.420 |
Why?
|
| Adiposity | 1 | 2014 | 237 | 0.420 |
Why?
|
| Adipose Tissue | 1 | 2017 | 769 | 0.420 |
Why?
|
| Endoscopic Mucosal Resection | 2 | 2023 | 94 | 0.410 |
Why?
|
| Gastrointestinal Diseases | 1 | 2016 | 589 | 0.400 |
Why?
|
| ROC Curve | 5 | 2021 | 1183 | 0.400 |
Why?
|
| Liver Diseases | 1 | 2016 | 574 | 0.390 |
Why?
|
| Prognosis | 11 | 2021 | 21713 | 0.390 |
Why?
|
| Premature Birth | 1 | 2015 | 407 | 0.380 |
Why?
|
| Age Factors | 7 | 2020 | 5377 | 0.370 |
Why?
|
| Risk | 7 | 2020 | 1972 | 0.370 |
Why?
|
| Sex Factors | 8 | 2020 | 2139 | 0.370 |
Why?
|
| Biopsy | 4 | 2022 | 3443 | 0.370 |
Why?
|
| Pregnant Women | 1 | 2011 | 162 | 0.370 |
Why?
|
| Insulin | 1 | 2015 | 1454 | 0.350 |
Why?
|
| Inflammation | 2 | 2018 | 2522 | 0.340 |
Why?
|
| Prospective Studies | 13 | 2023 | 12873 | 0.320 |
Why?
|
| Colonoscopy | 3 | 2023 | 518 | 0.320 |
Why?
|
| Survival Analysis | 6 | 2019 | 9180 | 0.310 |
Why?
|
| United Kingdom | 5 | 2019 | 257 | 0.310 |
Why?
|
| Age Distribution | 3 | 2022 | 698 | 0.310 |
Why?
|
| Vitamin D | 2 | 2021 | 261 | 0.310 |
Why?
|
| Area Under Curve | 4 | 2021 | 700 | 0.310 |
Why?
|
| Australia | 4 | 2017 | 225 | 0.310 |
Why?
|
| HIV Infections | 2 | 2019 | 2134 | 0.300 |
Why?
|
| Follow-Up Studies | 6 | 2022 | 14889 | 0.300 |
Why?
|
| Algorithms | 2 | 2022 | 3890 | 0.300 |
Why?
|
| Biomarkers | 2 | 2020 | 5047 | 0.290 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2018 | 173 | 0.290 |
Why?
|
| Proportional Hazards Models | 5 | 2019 | 4988 | 0.290 |
Why?
|
| Aspartate Aminotransferases | 2 | 2016 | 153 | 0.280 |
Why?
|
| Time Factors | 7 | 2020 | 12926 | 0.280 |
Why?
|
| Skin Neoplasms | 2 | 2020 | 4654 | 0.270 |
Why?
|
| Cytokines | 2 | 2016 | 2809 | 0.260 |
Why?
|
| Confidence Intervals | 2 | 2019 | 756 | 0.250 |
Why?
|
| Gastritis | 2 | 2019 | 373 | 0.250 |
Why?
|
| Hyperplasia | 2 | 2022 | 557 | 0.240 |
Why?
|
| Adolescent | 12 | 2021 | 31252 | 0.240 |
Why?
|
| Databases, Factual | 3 | 2021 | 2218 | 0.240 |
Why?
|
| Diet, Mediterranean | 1 | 2023 | 14 | 0.230 |
Why?
|
| Phospholipases A2, Calcium-Independent | 1 | 2022 | 13 | 0.220 |
Why?
|
| Melanoma | 1 | 2020 | 5317 | 0.220 |
Why?
|
| Arsenic | 1 | 2023 | 49 | 0.220 |
Why?
|
| Acyltransferases | 1 | 2022 | 62 | 0.220 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 5061 | 0.210 |
Why?
|
| Genotype | 3 | 2022 | 4109 | 0.210 |
Why?
|
| Germ-Line Mutation | 2 | 2018 | 1046 | 0.210 |
Why?
|
| Primary Health Care | 3 | 2023 | 787 | 0.200 |
Why?
|
| Hospitals, Veterans | 3 | 2018 | 397 | 0.200 |
Why?
|
| Natural Language Processing | 1 | 2022 | 119 | 0.200 |
Why?
|
| Esophagitis, Peptic | 1 | 2021 | 36 | 0.200 |
Why?
|
| Waist-Hip Ratio | 3 | 2019 | 59 | 0.200 |
Why?
|
| Social Class | 1 | 2023 | 310 | 0.200 |
Why?
|
| Principal Component Analysis | 2 | 2018 | 218 | 0.190 |
Why?
|
| Gastric Mucosa | 2 | 2022 | 613 | 0.190 |
Why?
|
| Physical Fitness | 1 | 2021 | 122 | 0.190 |
Why?
|
| Multiple Myeloma | 2 | 2022 | 2138 | 0.190 |
Why?
|
| North America | 2 | 2019 | 314 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 1362 | 0.190 |
Why?
|
| Diet Records | 1 | 2020 | 77 | 0.190 |
Why?
|
| Residence Characteristics | 1 | 2023 | 348 | 0.190 |
Why?
|
| Recurrence | 3 | 2018 | 4758 | 0.180 |
Why?
|
| Nutritive Value | 1 | 2020 | 96 | 0.180 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2020 | 78 | 0.180 |
Why?
|
| Gene-Environment Interaction | 2 | 2017 | 166 | 0.180 |
Why?
|
| Dietary Fiber | 1 | 2020 | 123 | 0.180 |
Why?
|
| Safety-net Providers | 1 | 2020 | 53 | 0.180 |
Why?
|
| Dietary Carbohydrates | 1 | 2020 | 134 | 0.170 |
Why?
|
| Medicare | 2 | 2022 | 860 | 0.170 |
Why?
|
| Hepacivirus | 1 | 2022 | 397 | 0.170 |
Why?
|
| Ablation Techniques | 1 | 2021 | 148 | 0.170 |
Why?
|
| Hysterectomy | 1 | 2023 | 611 | 0.170 |
Why?
|
| Genetic Pleiotropy | 1 | 2018 | 29 | 0.170 |
Why?
|
| Survival Rate | 3 | 2020 | 12221 | 0.170 |
Why?
|
| Hepatitis B | 1 | 2021 | 258 | 0.170 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2019 | 297 | 0.170 |
Why?
|
| Neoplasm Staging | 3 | 2021 | 13658 | 0.160 |
Why?
|
| Chromosome Mapping | 1 | 2022 | 1471 | 0.160 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2019 | 163 | 0.160 |
Why?
|
| Fruit | 1 | 2020 | 294 | 0.160 |
Why?
|
| Epidemiological Monitoring | 1 | 2018 | 73 | 0.160 |
Why?
|
| Capsule Endoscopy | 1 | 2018 | 26 | 0.160 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 374 | 0.160 |
Why?
|
| Metabolic Syndrome | 1 | 2021 | 353 | 0.150 |
Why?
|
| Sarcoma, Kaposi | 1 | 2019 | 187 | 0.150 |
Why?
|
| Guideline Adherence | 1 | 2022 | 636 | 0.150 |
Why?
|
| Energy Intake | 1 | 2020 | 515 | 0.150 |
Why?
|
| Sex Distribution | 2 | 2016 | 495 | 0.150 |
Why?
|
| Reproducibility of Results | 4 | 2020 | 6009 | 0.150 |
Why?
|
| Multifactorial Inheritance | 1 | 2017 | 148 | 0.150 |
Why?
|
| Molecular Epidemiology | 1 | 2017 | 246 | 0.150 |
Why?
|
| Work Schedule Tolerance | 1 | 2016 | 53 | 0.140 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2016 | 27 | 0.140 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2016 | 28 | 0.140 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2017 | 51 | 0.140 |
Why?
|
| Interferon-gamma Release Tests | 1 | 2017 | 87 | 0.140 |
Why?
|
| Protective Factors | 1 | 2016 | 106 | 0.140 |
Why?
|
| Regression Analysis | 1 | 2019 | 1546 | 0.140 |
Why?
|
| Celiac Disease | 1 | 2016 | 75 | 0.130 |
Why?
|
| Duodenum | 1 | 2016 | 149 | 0.130 |
Why?
|
| Cause of Death | 1 | 2019 | 752 | 0.130 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 4320 | 0.130 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2018 | 340 | 0.130 |
Why?
|
| Software | 1 | 2022 | 1321 | 0.130 |
Why?
|
| Keratinocytes | 1 | 2016 | 241 | 0.130 |
Why?
|
| Quality Indicators, Health Care | 1 | 2018 | 348 | 0.130 |
Why?
|
| Glutathione Transferase | 1 | 2016 | 359 | 0.130 |
Why?
|
| Geography | 3 | 2020 | 140 | 0.130 |
Why?
|
| Hepatitis B, Chronic | 1 | 2016 | 137 | 0.130 |
Why?
|
| Schistosoma japonicum | 2 | 2012 | 10 | 0.130 |
Why?
|
| Apgar Score | 1 | 2014 | 55 | 0.130 |
Why?
|
| Self Report | 1 | 2018 | 756 | 0.130 |
Why?
|
| Hernia, Hiatal | 1 | 2014 | 63 | 0.120 |
Why?
|
| Alcoholic Beverages | 1 | 2014 | 22 | 0.120 |
Why?
|
| Surveys and Questionnaires | 2 | 2016 | 5687 | 0.120 |
Why?
|
| Gastroenterology | 1 | 2017 | 195 | 0.120 |
Why?
|
| Liver | 2 | 2021 | 2961 | 0.120 |
Why?
|
| Patient Compliance | 1 | 2018 | 667 | 0.120 |
Why?
|
| Comorbidity | 1 | 2021 | 2352 | 0.120 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2017 | 426 | 0.110 |
Why?
|
| Diagnostic Errors | 1 | 2017 | 509 | 0.110 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2016 | 272 | 0.110 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2017 | 363 | 0.110 |
Why?
|
| Policy Making | 1 | 2013 | 85 | 0.110 |
Why?
|
| Catheter Ablation | 1 | 2018 | 620 | 0.110 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 860 | 0.110 |
Why?
|
| DNA Mutational Analysis | 1 | 2018 | 2283 | 0.110 |
Why?
|
| Anticholesteremic Agents | 1 | 2015 | 256 | 0.110 |
Why?
|
| Biomarkers, Tumor | 3 | 2020 | 10331 | 0.100 |
Why?
|
| New South Wales | 1 | 2011 | 8 | 0.100 |
Why?
|
| Schistosomiasis | 1 | 2012 | 63 | 0.100 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 4971 | 0.100 |
Why?
|
| Hypertension | 1 | 2021 | 1503 | 0.100 |
Why?
|
| Beer | 1 | 2011 | 4 | 0.100 |
Why?
|
| Schistosomiasis japonica | 1 | 2011 | 6 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 461 | 0.100 |
Why?
|
| Body Weight | 1 | 2016 | 1293 | 0.100 |
Why?
|
| Cattle Diseases | 1 | 2011 | 22 | 0.100 |
Why?
|
| Wine | 1 | 2011 | 19 | 0.100 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2015 | 228 | 0.100 |
Why?
|
| Ovarian Neoplasms | 2 | 2018 | 4638 | 0.100 |
Why?
|
| Tuberculosis | 1 | 2017 | 548 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 1323 | 0.100 |
Why?
|
| Age of Onset | 1 | 2013 | 827 | 0.100 |
Why?
|
| Computer Terminals | 1 | 2010 | 12 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 1054 | 0.090 |
Why?
|
| Pregnancy | 2 | 2014 | 7573 | 0.090 |
Why?
|
| Ultrasonography | 1 | 2016 | 1863 | 0.090 |
Why?
|
| Phenotype | 2 | 2018 | 6295 | 0.090 |
Why?
|
| Sex Characteristics | 2 | 2023 | 417 | 0.090 |
Why?
|
| Antiviral Agents | 1 | 2016 | 1230 | 0.090 |
Why?
|
| Antibodies, Bacterial | 1 | 2011 | 380 | 0.090 |
Why?
|
| Clinical Competence | 1 | 2017 | 1270 | 0.090 |
Why?
|
| Metabolic Diseases | 1 | 2010 | 130 | 0.080 |
Why?
|
| Adolescent Behavior | 1 | 2010 | 230 | 0.080 |
Why?
|
| Meta-Analysis as Topic | 2 | 2019 | 276 | 0.070 |
Why?
|
| Patient Selection | 1 | 2014 | 2055 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2018 | 32848 | 0.070 |
Why?
|
| Decision Making | 1 | 2013 | 1287 | 0.060 |
Why?
|
| Electronic Health Records | 2 | 2022 | 929 | 0.060 |
Why?
|
| Geography, Medical | 1 | 2023 | 21 | 0.060 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2023 | 44 | 0.060 |
Why?
|
| Phospholipases | 1 | 2022 | 13 | 0.060 |
Why?
|
| Lipase | 1 | 2022 | 112 | 0.050 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2022 | 58 | 0.050 |
Why?
|
| Sentinel Surveillance | 2 | 2012 | 34 | 0.050 |
Why?
|
| Praziquantel | 2 | 2012 | 15 | 0.050 |
Why?
|
| Anthelmintics | 2 | 2012 | 69 | 0.050 |
Why?
|
| Sunburn | 1 | 2021 | 35 | 0.050 |
Why?
|
| Pigmentation | 1 | 2021 | 47 | 0.050 |
Why?
|
| Child | 4 | 2021 | 29154 | 0.050 |
Why?
|
| Cholagogues and Choleretics | 1 | 2020 | 33 | 0.050 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2020 | 51 | 0.050 |
Why?
|
| Cattle | 2 | 2012 | 783 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 10035 | 0.040 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2019 | 110 | 0.040 |
Why?
|
| Serine Endopeptidases | 1 | 2020 | 275 | 0.040 |
Why?
|
| Medically Uninsured | 1 | 2020 | 102 | 0.040 |
Why?
|
| Eye Proteins | 1 | 2020 | 269 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2019 | 460 | 0.040 |
Why?
|
| Causality | 1 | 2018 | 178 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2020 | 481 | 0.040 |
Why?
|
| Morbidity | 1 | 2019 | 397 | 0.040 |
Why?
|
| Health Behavior | 1 | 2022 | 603 | 0.040 |
Why?
|
| Weight Loss | 1 | 2021 | 627 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 1146 | 0.040 |
Why?
|
| Learning Curve | 1 | 2017 | 68 | 0.040 |
Why?
|
| Aftercare | 1 | 2018 | 259 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 2195 | 0.040 |
Why?
|
| Queensland | 1 | 2016 | 4 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 672 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2018 | 477 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2012 | 1945 | 0.030 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2018 | 128 | 0.030 |
Why?
|
| Medical History Taking | 1 | 2016 | 173 | 0.030 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2016 | 215 | 0.030 |
Why?
|
| Elective Surgical Procedures | 1 | 2016 | 250 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 573 | 0.030 |
Why?
|
| Hepatitis B virus | 1 | 2016 | 217 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 984 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2016 | 546 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2016 | 974 | 0.030 |
Why?
|
| Colon | 1 | 2017 | 670 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 2017 | 390 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2018 | 1529 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2019 | 1910 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2018 | 1085 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2022 | 2819 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 1363 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 2594 | 0.030 |
Why?
|
| Taiwan | 1 | 2011 | 93 | 0.020 |
Why?
|
| Drug Therapy | 1 | 2012 | 205 | 0.020 |
Why?
|
| China | 1 | 2012 | 606 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2010 | 92 | 0.020 |
Why?
|
| Mass Screening | 1 | 2018 | 1509 | 0.020 |
Why?
|
| Puberty | 1 | 2010 | 104 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 2437 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2016 | 1129 | 0.020 |
Why?
|
| Television | 1 | 2010 | 74 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 6207 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2016 | 1549 | 0.020 |
Why?
|
| Rural Population | 1 | 2011 | 281 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 2403 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2012 | 16273 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 7548 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2016 | 11965 | 0.010 |
Why?
|
| Animals | 2 | 2012 | 59536 | 0.010 |
Why?
|